Crinetics Pharmaceuticals (CRNX) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.63% |
| Dec 31, 2025 | 5.90% |
| Sep 30, 2025 | 9.01% |
| Jun 30, 2025 | 5.78% |
| Mar 31, 2025 | 5.90% |
| Dec 31, 2024 | -56.96% |
| Sep 30, 2024 | 0.03% |
| Jun 30, 2024 | 4.22% |
| Mar 31, 2024 | -61.30% |
| Dec 31, 2023 | -291.16% |
| Sep 30, 2023 | -255.03% |
| Jun 30, 2023 | 3.92% |
| Mar 31, 2023 | -20.84% |
| Dec 31, 2022 | 90.60% |
| Sep 30, 2022 | -490.40% |
| Jun 30, 2022 | 80.49% |
| Mar 31, 2022 | -58.86% |
| Dec 31, 2021 | -4.11% |
| Sep 30, 2021 | 5.12% |
| Jun 30, 2021 | -35.24% |
| Mar 31, 2021 | 11.83% |
| Dec 31, 2020 | 8.53% |
| Sep 30, 2020 | 8.94% |
| Jun 30, 2020 | -81.88% |
| Mar 31, 2020 | 4.72% |
| Dec 31, 2019 | 10.09% |
| Sep 30, 2019 | 42.82% |
| Jun 30, 2019 | -46.46% |
| Mar 31, 2019 | 4.07% |
| Dec 31, 2018 | 3.41% |
| Sep 30, 2018 | -148.00% |